These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 26104054)
21. Serum 25-hydroxyvitamin D levels in vitamin D-insufficient hip fracture patients after supplementation with ergocalciferol and cholecalciferol. Glendenning P; Chew GT; Seymour HM; Gillett MJ; Goldswain PR; Inderjeeth CA; Vasikaran SD; Taranto M; Musk AA; Fraser WD Bone; 2009 Nov; 45(5):870-5. PubMed ID: 19631774 [TBL] [Abstract][Full Text] [Related]
22. Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: implications for treatment and prophylaxis. Cipriani C; Romagnoli E; Pepe J; Russo S; Carlucci L; Piemonte S; Nieddu L; McMahon DJ; Singh R; Minisola S J Clin Endocrinol Metab; 2013 Jul; 98(7):2709-15. PubMed ID: 23766519 [TBL] [Abstract][Full Text] [Related]
23. Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis. Boyle MP; Noschese ML; Watts SL; Davis ME; Stenner SE; Lechtzin N Am J Respir Crit Care Med; 2005 Jul; 172(2):212-7. PubMed ID: 15860755 [TBL] [Abstract][Full Text] [Related]
24. Vitamin D deficiency and its correction in children with sickle cell anaemia. Wykes C; Arasaretnam A; O'Driscoll S; Farnham L; Moniz C; Rees DC Ann Hematol; 2014 Dec; 93(12):2051-6. PubMed ID: 24981689 [TBL] [Abstract][Full Text] [Related]
25. Effect of cholecalciferol recommended daily allowances on vitamin D status and fibroblast growth factor-23: an observational study in acute burn patients. Rousseau AF; Damas P; Ledoux D; Cavalier E Burns; 2014 Aug; 40(5):865-70. PubMed ID: 24462294 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. Blair D; Byham-Gray L; Lewis E; McCaffrey S J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303 [TBL] [Abstract][Full Text] [Related]
27. A Retrospective Evaluation of Response to Vitamin D Supplementation in Obese Versus Nonobese Patients. Bryant GA; Koenigsfeld CF; Lehman NP; Smith HL; Logemann CD; Phillips KT J Pharm Pract; 2015 Dec; 28(6):543-7. PubMed ID: 25124377 [TBL] [Abstract][Full Text] [Related]
28. Prevention and treatment of vitamin D deficiency. Sinha A; Cheetham TD; Pearce SH Calcif Tissue Int; 2013 Feb; 92(2):207-15. PubMed ID: 23124916 [TBL] [Abstract][Full Text] [Related]
29. A randomized double-blinded placebo controlled trial of ergocalciferol 40,000 versus 100,000 IU per week for vitamin D inadequacy in institutionalized postmenopausal women. Mueangpaisarn P; Chaiamnuay S Aging Clin Exp Res; 2020 Jan; 32(1):41-48. PubMed ID: 30784012 [TBL] [Abstract][Full Text] [Related]
30. [Vitamin D2 or vitamin D3?]. Mistretta VI; Delanaye P; Chapelle JP; Souberbielle JC; Cavalier E Rev Med Interne; 2008 Oct; 29(10):815-20. PubMed ID: 18406498 [TBL] [Abstract][Full Text] [Related]
31. Can Stoss Therapy Be Used in Children with Vitamin D Deficiency or Insufficiency without Rickets? Koçyiğit C; Çatlı G; İnce G; Özkan EB; Dündar BN J Clin Res Pediatr Endocrinol; 2017 Jun; 9(2):150-155. PubMed ID: 28077342 [TBL] [Abstract][Full Text] [Related]
32. Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis. Boas SR; Hageman JR; Ho LT; Liveris M J Cyst Fibros; 2009 Jul; 8(4):270-2. PubMed ID: 19447079 [TBL] [Abstract][Full Text] [Related]
33. Differential effects of different vitamin D replacement strategies in patients with diabetes. Alam U; Chan AW; Buazon A; Van Zeller C; Berry JL; Jugdey RS; Asghar O; Cruickshank JK; Petropoulos IN; Malik RA J Diabetes Complications; 2014; 28(1):66-70. PubMed ID: 24139562 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults. Binkley N; Gemar D; Engelke J; Gangnon R; Ramamurthy R; Krueger D; Drezner MK J Clin Endocrinol Metab; 2011 Apr; 96(4):981-8. PubMed ID: 21289249 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of vitamin D repletion regimens to correct vitamin D status in adults. Pepper KJ; Judd SE; Nanes MS; Tangpricha V Endocr Pract; 2009 Mar; 15(2):95-103. PubMed ID: 19342361 [TBL] [Abstract][Full Text] [Related]
36. Effect of high dose ergocalciferol in chronic kidney disease patients with 25-hydroxyvitamin D deficiency. Trakarnvanich T; Chalapipat O; Disthabanchong S; Kurathong S; Praditpornsilpa K; Stitchantrakul W; Chailurkit LO J Med Assoc Thai; 2010 Aug; 93(8):885-91. PubMed ID: 20718162 [TBL] [Abstract][Full Text] [Related]
37. Ergocalciferol Supplementation in Hemodialysis Patients With Vitamin D Deficiency: A Randomized Clinical Trial. Miskulin DC; Majchrzak K; Tighiouart H; Muther RS; Kapoian T; Johnson DS; Weiner DE J Am Soc Nephrol; 2016 Jun; 27(6):1801-10. PubMed ID: 26677862 [TBL] [Abstract][Full Text] [Related]
38. Comparative efficacy and safety of different doses of ergocalciferol supplementation in patients with metabolic syndrome. Sansanayudh N; Wongwiwatthananukit S; Phetkrajaysang N; Krittiyanunt S Int J Clin Pharm; 2014 Aug; 36(4):771-8. PubMed ID: 24853094 [TBL] [Abstract][Full Text] [Related]
39. Response of Vitamin D Concentration to Vitamin D3 Administration in Older Adults without Sun Exposure: A Randomized Double-Blind Trial. Schwartz JB; Kane L; Bikle D J Am Geriatr Soc; 2016 Jan; 64(1):65-72. PubMed ID: 26782853 [TBL] [Abstract][Full Text] [Related]
40. Prevalence of 25-OH vitamin D deficiency in a population of hemodialysis patients and efficacy of an oral ergocalciferol supplementation regimen. Porter A; Gilmartin C; Srisakul U; Arruda J; Akkina S Am J Nephrol; 2013; 37(6):568-74. PubMed ID: 23735861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]